INFLAMMATORY BOWEL DISEASE-SPECIFIC OUTCOMES ARE NOT ASSOCIATED WITH INITIAL BACTERIAL CHOLANGITIS EPISODE IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS

被引：0
|
作者：
Rosenblatt, Russell [1 ]
Lukin, Dana [2 ]
Tafesh, Zaid [3 ]
Shen, Nicole T. [3 ]
Kumar, Sonal [2 ]
Lucero, Catherine [1 ]
Jesudian, Arun B. [1 ]
Brown, Robert S., Jr. [1 ]
Fortune, Brett E. [1 ]
Verna, Elizabeth C. [4 ]
机构：
[1] Weill Cornell Med, Ctr Liver Dis & Transplantat, New York, NY USA
[2] Weill Cornell Med, Gastroenterol & Hepatol, New York, NY USA
[3] New York Presbyterian Hosp Program, New York, NY USA
[4] Columbia Univ, Med Ctr, Transplant Hepatol, New York, NY 10027 USA
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1318
引用
收藏
页码：801A / 801A
页数：1
相关论文
共 50 条
  • [31] Inflammatory bowel disease course in patients transplanted for primary sclerosing cholangitis
    Wallack, Ariana
    Levine, Joel S.
    Forman, Lisa
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 287 - 288
  • [32] Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease
    Sayed, Amr
    Assis, David N.
    Silveira, Marina G.
    Deng, Yanhong
    Ciarleglio, Maria
    Gaidos, Jill K. J.
    Proctor, Deborah D.
    Al-Bawardy, Badr
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (03) : 270 - 274
  • [33] SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL-DISEASE
    FREESE, D
    LATIMER, JS
    GILBERSTADT, S
    KANE, W
    SHARP, HL
    CLINICAL PEDIATRICS, 1982, 21 (01) : 11 - 16
  • [34] Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease
    O'Toole, Aoibhlinn
    Alakkari, Alaa
    Keegan, Denise
    Doherty, Glen
    Mulcahy, Hugh
    O'Donoghue, Diarmuid
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (04) : 439 - 441
  • [35] Risk of colorectal cancer in patients with primary sclerosing cholangitis and concomitant inflammatory bowel disease compared with primary sclerosing cholangitis only
    Das, Taranika Sarkar
    Ho, Kimberly
    Udaikumar, Jahnavi
    Chen, Bryan
    Delau, Olivia
    Shaukat, Aasma
    Jacobson, Ira
    Sarwar, Raiya
    HEPATOLOGY RESEARCH, 2024, 54 (09) : 807 - 816
  • [36] Associations Between Drug Exposure and Outcomes in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Fung, Brian M.
    Ali, Ahmad H.
    Tabibian, James H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (05) : 1244 - 1245
  • [37] CLINICAL AND TRANSLATIONAL OUTCOMES IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE RECEIVING VEDOLIZUMAB
    Williamson, Kate D.
    Slevin, Stephanie
    Willberg, Christian
    Chapman, Roger W.
    Klenerman, Paul
    Keshav, Satish
    GASTROENTEROLOGY, 2017, 152 (05) : S1186 - S1187
  • [38] RACE INFLUENCES CLINICAL OUTCOMES OF PATIENTS WTIH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE
    Haj, Mona
    Bickford, Megan M.
    Forster, Erin M.
    GASTROENTEROLOGY, 2020, 158 (06) : S444 - S445
  • [39] Clinical and translational outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease receiving vedolizumab
    Williamson, K. D.
    Slevin, S.
    Willberg, C.
    Chapman, R.
    Klenerman, P.
    Keshav, S.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S544 - S545
  • [40] Survival outcomes of primary sclerosing cholangitis patients with inflammatory bowel disease after liver transplantation
    Peverelle, M.
    Paleri, S.
    Hughes, J.
    Testro, A.
    Angus, P.
    De Cruz, P.
    Gow, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 64 - 65
12345